Search by Drug Name or NDC

    NDC 59779-0823-56 Triple Antibiotic and Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g Details

    Triple Antibiotic and Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g

    Triple Antibiotic and Pain Relief is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE.

    Product Information

    NDC 59779-0823
    Product ID 59779-823_5e900ecc-7701-4d6d-a908-37c68eb6c66c
    Associated GPIs 90109804434220
    GCN Sequence Number 047690
    GCN Sequence Number Description neomycn/bacitrc/polymyx/pramox OINT. (G) 3.5-10K-10 TOPICAL
    HIC3 Q5W
    HIC3 Description TOPICAL ANTIBIOTICS
    GCN 12623
    HICL Sequence Number 035595
    HICL Sequence Number Description NEOMYCIN SULF/BACITRACIN ZINC/POLYMYXIN B SULF/PRAMOXINE HCL
    Brand/Generic Generic
    Proprietary Name Triple Antibiotic and Pain Relief
    Proprietary Name Suffix Maximum Strength
    Non-Proprietary Name bacitracin zinc, neomycin sulfate, polymyxin b sulfate and pramoxine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form OINTMENT
    Route TOPICAL
    Active Ingredient Strength 500; 3.5; 10000; 10
    Active Ingredient Units [USP'U]/g; mg/g; [USP'U]/g; mg/g
    Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
    Labeler Name CVS Pharmacy
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M004
    Listing Certified Through n/a

    Package

    NDC 59779-0823-56 (59779082356)

    NDC Package Code 59779-823-56
    Billing NDC 59779082356
    Package 1 TUBE in 1 CARTON (59779-823-56) / 28 g in 1 TUBE
    Marketing Start Date 2005-01-03
    NDC Exclude Flag N
    Pricing Information N/A